Search hospitals
>
Florida
>
Tampa
Moffitt Cancer Center
Claim this profile
Tampa, Florida 33612
Global Leader in Lung Cancer
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Pancreatic Cancer
Conducts research for Melanoma
1668 reported clinical trials
223 medical researchers
Summary
Moffitt Cancer Center is a medical facility located in Tampa, Florida. This center is recognized for care of Lung Cancer, Cancer, Breast Cancer, Pancreatic Cancer, Melanoma and other specialties. Moffitt Cancer Center is involved with conducting 1,668 clinical trials across 977 conditions. There are 223 research doctors associated with this hospital, such as Jonathan Metts, MD, Andrew Brohl, MD, Nikhil Khushalani, MD, and Zeynep Eroglu.
Area of expertise
Lung Cancer
Moffitt Cancer Center has run 253 trials for Lung Cancer. Some of their research focus areas include:
Cancer
Moffitt Cancer Center has run 245 trials for Cancer. Some of their research focus areas include:
Top PIs
Jonathan Metts, MD
Johns Hopkins All Children's Hospital
5 years of reported clinical research
Andrew Brohl, MD
Moffitt Cancer Center
6 years of reported clinical research
Nikhil Khushalani, MD
Moffitt Cancer Center
2 years of reported clinical research
Zeynep Eroglu
Moffitt Cancer Center
6 years of reported clinical research
Clinical Trials running at Moffitt Cancer Center
Lung Cancer
Skin Cancer
Prostate Cancer
Cancer
Breast Cancer
Brain Tumor
Non-Hodgkin's Lymphoma
Multiple Myeloma
Non-Small Cell Lung Cancer
Bladder Cancer
Focused Ultrasound + Immunotherapy
for Brain Cancer
The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier opening with Exablate Model 4000 Type 2.0/2.1 for the treatment of NSCLC brain metastases in patients who are undergoing planned FDA approved, on-label systemic therapy utilizing immune checkpoint inhibitors.
Recruiting
3 awards
Phase 3
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Stereotactic Radiosurgery vs Whole-Brain Radiotherapy
for Brain Metastasis from Lung Cancer
This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue. Whole brain radiation therapy delivers a low dose of radiation to the entire brain including the normal brain tissue. Hippocampal avoidance during whole-brain radiation therapy (HA-WBRT) decreases the amount of radiation that is delivered to the hippocampus which is a brain structure that is important for memory. The drug, memantine, is also often given with whole brain radiotherapy because it may decrease the risk of side effects related to thinking and memory. Stereotactic radiosurgery may decrease side effects related to memory and thinking compared to standard of care HA-WBRT plus memantine.
Recruiting
2 awards
Phase 3
15 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Moffitt Cancer Center?
Moffitt Cancer Center is a medical facility located in Tampa, Florida. This center is recognized for care of Lung Cancer, Cancer, Breast Cancer, Pancreatic Cancer, Melanoma and other specialties. Moffitt Cancer Center is involved with conducting 1,668 clinical trials across 977 conditions. There are 223 research doctors associated with this hospital, such as Jonathan Metts, MD, Andrew Brohl, MD, Nikhil Khushalani, MD, and Zeynep Eroglu.
Where is Moffitt Cancer Center located?
**Directions to Moffitt Cancer Center, Tampa, Florida:** - From I-275, take the Fletcher Avenue exit and proceed west. - Turn left onto USF Magnolia Drive and continue south to reach Moffitt Cancer Center.
Who should I call to ask about financial aid or insurance network?
**Moffitt Cancer Center Financial and Patient Assistance Information:** - **Financial Assistance:** Contact Moffitt Customer Service at 1-800-456-3434 ext. 8422 or custservbusoff2@moffitt.org, Monday - Friday, 8 a.m. – 5 p.m., or visit the business offices at Moffitt locations, Monday - Friday, 8:00 a.m. – 4:30 p.m. Services include billing inquiries, payments, estimated services, hospital pricing, payment arrangements, Medicaid and Social Security disability application assistance, and financing options. - **Insurance and Billing Questions:** Call 813-745-8422 for hospital, physician, or clinic charges inquiries. - **Medical Records Requests:** - Radiology or films/CDs: 813-745-8651 - Pathology slides: 813-745-3001 - All other medical records: 813-745-3991 - **Disability Assistance:** For Long-Term or Short-Term Disability application assistance, call 813-745-2356. - **Patient Assistance Programs:** For help with drug costs or co-pays, contact Moffitt's Publix Pharmacy at 813-745-8484 or Moffitt's Specialty Pharmacy at 813-745-7354. - **Authorization or Eligibility Questions:** Contact the Patient Financial Clearance Unit at 1-800-456-3434 ext. 7300, Monday - Friday, 8 a.m. – 5 p.m. - **General Insurance and Financial Information:** Visit the Insurance & Financial Information page on the Moffitt Cancer Center website for comprehensive details on financial assistance and insurance.
What insurance does Moffitt Cancer Center accept?
The Moffitt Cancer Center and Moffitt Medical Group accept a wide range of health insurance plans, including but not limited to Aetna HMO & PPO, Amerigroup Medicaid HMO, AvMed HMO, Beech Street PPO, various Blue Cross Blue Shield plans, ChampVA, CIGNA HMO & PPO, Coventry Health Plan HMO & PPO, Devoted Health Medicare HMO & PPO, Humana HMO & PPO, Medicaid, Medicare, Molina Medicaid and Medicare HMO, Tricare Prime and Select, and United Healthcare HMO & PPO. Many managed care plans require specific prerequisites for consultation and treatment. Patients are advised to consult their insurance provider for any special instructions to ensure coverage for services at the H. Lee Moffitt Cancer Center & Research Institute.
What awards or recognition has Moffitt Cancer Center received?
Moffitt Cancer Center ranks No. 10 nationally for cancer treatment according to Newsweek in 2023, making it the top-ranked cancer hospital in Florida and the Southeast. It has been named to DiversityInc’s Top Hospitals & Health Systems List for eight consecutive years. Additionally, it has been recognized as a Leader in LGBTQ Healthcare Equality by the Human Rights Campaign Foundation for ten years.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.